Beam Therapeutics Inc.

Beam Therapeutics Inc.verified

BEAM

Price:

$28.96

Market Cap:

$2.40B

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disor...[Read more]

Industry

Biotechnology

IPO Date

2020-02-06

Stock Exchange

NASDAQ

Ticker

BEAM

The PE Ratio as of December 2024 (TTM) for Beam Therapeutics Inc. (BEAM) is -18.33

According to Beam Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -18.33. This represents a change of 449.69% compared to the average of -3.33 of the last 4 quarters.

Beam Therapeutics Inc. (BEAM) Historical PE Ratio (quarterly & annually)

How has BEAM PE Ratio performed in the past?

The mean historical PE Ratio of Beam Therapeutics Inc. over the last ten years is -14.92. The current -18.33 PE Ratio has changed 12.18% with respect to the historical average. Over the past ten years (40 quarters), BEAM's PE Ratio was at its highest in in the December 2023 quarter at 3.85. The PE Ratio was at its lowest in in the September 2021 quarter at -51.35.

Quarterly (TTM)
Annual

Average

-14.92

Median

-14.88

Minimum

-30.35

Maximum

-5.72

Beam Therapeutics Inc. (BEAM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Beam Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 114.68%

Maximum Annual PE Ratio = -5.72

Minimum Annual Increase = -81.17%

Minimum Annual PE Ratio = -30.35

Quarterly (TTM)
Annual
YearPE RatioChange
2023-15.8552.54%
2022-10.39-30.71%
2021-14.990.77%
2020-14.8821.25%
2019-12.27114.68%
2018-5.72-81.17%

Beam Therapeutics Inc. (BEAM) Average PE Ratio

How has BEAM PE Ratio performed in the past?

The current PE Ratio of Beam Therapeutics Inc. (BEAM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-13.74

5-year avg

-13.68

10-year avg

-14.92

Beam Therapeutics Inc. (BEAM) PE Ratio vs. Peers

How is BEAM’s PE Ratio compared to its peers?

Beam Therapeutics Inc.’s PE Ratio is less than Editas Medicine, Inc. (-0.48), less than CRISPR Therapeutics AG (-14.55), less than Caribou Biosciences, Inc. (-1.02), less than Verve Therapeutics, Inc. (-2.48), less than Intellia Therapeutics, Inc. (-2.35), less than Fate Therapeutics, Inc. (-1.09), less than Prime Medicine, Inc. (-1.49), greater than Vertex Pharmaceuticals Incorporated (-219.90), less than Ginkgo Bioworks Holdings, Inc. (-0.74), less than Sana Biotechnology, Inc. (-1.33),

Build a custom stock screener for Beam Therapeutics Inc. (BEAM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beam Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beam Therapeutics Inc. (BEAM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beam Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Beam Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for Beam Therapeutics Inc. (BEAM)?

What is the highest PE Ratio for Beam Therapeutics Inc. (BEAM)?

What is the 3-year average PE Ratio for Beam Therapeutics Inc. (BEAM)?

What is the 5-year average PE Ratio for Beam Therapeutics Inc. (BEAM)?

How does the current PE Ratio for Beam Therapeutics Inc. (BEAM) compare to its historical average?